Sustained-release GLP-1 receptor agonists (GLP-1RAs) are a type of medication that slowly releases GLP-1RA into the bloodstream over time, which allows for longer-lasting effects and less frequent injections compared to traditional GLP-1RAs
Exploring the uncharted therapeutic potentials of naringin, this study delves into its mitigating effects on disruptions in kallikrein-3 levels, steroidal-thyroidal hormone balance, and antioxidant defense triggered by PE-MPs exposure, paving the way for novel interventions in environmental toxin-induced endocrine and oxidative stress disorders
Eyles JE, Spiers ID, Williamson ED, Alpar HO
For instance, GLP-1s could help the US opioid crisis, which costs $1.5 trillion a year the cost of many people dying young or living with serious consequences
"Its an exciting area of research and I think therapies targeting cellular metabolism deserve continued scientific attention," the New York-based expert told Fox News Digital